Porphyromonas gingivalis Promotes Oral Squamous Cell Carcinoma Progression by Modulating Autophagy

ABSTRACT Objectives Porphyromonas gingivalis (P. gingivalis) is a keystone periodontal pathogen associated with various gastro‐intestinal tract cancers. However, whether P. gingivalis can promote oral squamous cell carcinoma (OSCC) and the underlying mechanism associated with such promotion remain u...

Full description

Saved in:
Bibliographic Details
Published inOral diseases Vol. 31; no. 2; pp. 492 - 502
Main Authors Yuan, Keyong, Xu, Shengming, Liu, Guanglong, Han, Yong, Hu, Jingzhou, Zhang, Wuchang, Zhang, Zhiyuan, Liu, Liu, Huang, Zhengwei, Zhu, Yu, Liu, Shuli
Format Journal Article
LanguageEnglish
Published Denmark Wiley Subscription Services, Inc 01.02.2025
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:ABSTRACT Objectives Porphyromonas gingivalis (P. gingivalis) is a keystone periodontal pathogen associated with various gastro‐intestinal tract cancers. However, whether P. gingivalis can promote oral squamous cell carcinoma (OSCC) and the underlying mechanism associated with such promotion remain unclear. Materials and Methods In this study, OSCC xenograft models were used to evaluate the effects of P. gingivalis on tumor progression. The functional studies were done on several OSCC cell lines in vitro. P. gingivalis‐specific 16S rRNA fluorescent in situ hybridization (FISH) was used to test its prevalence in clinical samples. Results We found that P. gingivalis increased tumor volume and tumor growth in OSCC nude models. Functional studies demonstrated that P. gingivalis inhibited the apoptosis of OSCC cells by promoting cellular autophagy. P. gingivalis was more prevalent in FISH samples from patients with OSCC than from patients with leukoplakia or healthy subjects (70% vs. 47.2% vs. 33.3%, p = 0.045 and p < 0.001, respectively). Conclusion These data suggest that P. gingivalis plays an accelerating role in OSCC progression and contributes to OSCC by enhancing the autophagy pathway to reduce carcinoma apoptosis.
Bibliography:Keyong Yuan, Shengming Xu and Guanglong Liu are co‐first authors and contributed equally to this study.
This work was supported by the Fundamental research program funding of Ninth People's Hospital affiliated to Shanghai Jiao Tong university School of Medicine (JYZZ233, JYZZ240); the National Nature Science Foundation of China (grant number 81802696).
Funding
Correction added on 11th November 2024, after first online publication: The corresponding author has been updated.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1354-523X
1601-0825
1601-0825
DOI:10.1111/odi.15157